22. The effectiveness of intravenous iron surcrose supplementation in patients with severe anemia due to iron deficiency
Main Article Content
Abstract
This is an assessment of intravenous iron sucrose supplementation effectiveness in patients with severe anemia resulting from iron deficiency treated at Military Hospital 103. An uncontrolled interventional study was conducted on 103 patients with severe anemia caused by iron deficiency from January 2022 to February 2025. The median age of the patients was 48 years old, and females accounted for 64.1%. The most common cause of iron deficiency anemia was blood loss (65%). The median hemoglobin concentration was 62 g/L and 85.3% of patients had ferritin < 15 ng/mL initially. Post-treatment, hematological indices significantly improved (p < 0.0001), with hemoglobin increasing from 62 g/L to 95 g/L and ferritin increasing from 4.0 to 122.2 ng/mL. The mean hemoglobin level rose by 2.11 g/L per 100 mg of intravenous iron sucrose supplementation . 6.8% of patients experiencing mild reactions or nausea. Pre-treatment, hemoglobin and hematocrit were inversely correlated with hemoglobin increase, with hemoglobin showing the strongest effect (Beta = -0.476, p = 0.002). Intravenous iron sucrose supplementation provides rapid improvement in anemia, and is safe for patients with severe anemia caused by iron deficiency.
Article Details
Keywords
Iron deficiency anemia, intravenous iron supplementation, Military Hospital 103
References
2. Jericó C, Beverina I, Quintana-Diaz M, et al. Efficacy and safety of high-dose intravenous iron as the first-choice therapy in outpatients with severe iron deficiency anemia. Transfusion. 2020; 60(7): 1443-1449.
3. Iolascon A, Andolfo I, Russo R, et al. Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia. Hemasphere. 2024; 8(7): e108:1-16.
4. Omar M. Tackling Iron deficiency Anemia: A global Perspective on Diagnosis, Treatment and Prevention. American Journal of Medical and Clinical Research & Reviews. 2023; 2(10): 1-5.
5. Abouzid M, Tanashat M, Khlidj Y, et al. Efficacy and safety of intravenous iron therapy in heart failure patients with iron deficiency: a systematic review and meta-analysis of randomized controlled trials. European Heart Journal. 2024; 45(Supplement_1): ehae666. 3278.
6. Phạm Thị Thu Huyền, Nguyễn Hữu Dũng, Đỗ Gia Tuyển và cộng sự. Điều trị thiếu máu thiếu sắt bằng bổ sung sắt đường tĩnh mạch trên bệnh nhân thận nhân tạo chu kì. Tạp chí Y học Việt Nam. 2024; 535(1): 299-302.
7. Hung K-C, Chang L-C, Ho C-N, et al. Efficacy of intravenous iron supplementation in reducing transfusion risk following cardiac surgery: an updated meta-analysis of randomised controlled trials. British Journal of Anaesthesia. 2024; 133 (6): 1137-1149
8. Nguyễn Phương Linh Hoàng, Nguyễn Hồng Trương, Nguyễn Song Tú và cộng sự. Tình trạng thiếu máu và dự trữ sắt ở phụ nữ 15-35 tuổi tại một huyện miền núi phía Bắc, năm 2018. Tạp chí Y học Việt Nam. 2021; 507(2): 261-265.
9. Đỗ Thị Lý, Phạm Thi Thu Hằng, Phạm Văn Phương và cộng sự. Đánh giá hiệu quả truyền khối hồng cầu tại Khoa Huyết học lâm sàng-Bệnh viện Trung ương Quân đội 108. Journal of 108-Clinical Medicine and Phamarcy. 2022; 237-243.
10. Findikli HA, Tutak AS. The effects of severe iron deficiency anemia on T-wave intervals. Archives of Clinical and Biomedical Research. 2018; 2(6): 233-238.
13. Auerbach M, Staffa SJ, Brugnara C. Using reticulocyte hemoglobin equivalent as a marker for iron deficiency and responsiveness to iron therapy. Elsevier; 2021: 1510-1519.
14. Sabe R, Vatsayan A, Mahran A, Khalili AS, Ahuja S, Sferra TJ. Safety and efficacy of intravenous iron sucrose for iron-deficiency anemia in children and adolescents with inflammatory bowel disease. Global Pediatric Health. 2019; 6: 1-7
15. Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Elsevier. 2015: 12-23.